Projects per year
Fingerprint
Dive into the research topics where Aubin Pitiot is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
PSEUDO: Pre-clinical validation of CoMiX and Bikes/Trikes against infections with Pseudomonas aeruginosa
Seguin-Devaux, C. (PI), Zimmer, J. (Partner), Si-Tahar, M. (Partner) & Pitiot, A. (Partner)
FNR - Fonds National de la Recherche
1/02/23 → 30/04/26
Project: Research
-
Directed-Complement Activation as a Novel Immunotherapeutic Approach for HER2-Breast Cancer
Seguin-Devaux, C., Brandus, B., Plesseria, J. M., Iserentant, G., Servais, J. Y., Pitiot, A., Kanli, G., Behrmann, I., Schober, R., Zimmer, J., Cohen, J. H. M. & Dervillez, X., 5 Sept 2025, In: ImmunoTargets and Therapy. 14, p. 979-995 17 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
Directed-complement killing of Pseudomonas aeruginosa protects against lethal pneumonia
Pitiot, A., Brandus, B., Iserentant, G., Rolin, C., Servais, J. Y., Fouquenet, D., Chesnay, A., Richert, L., Briard, B., Si-Tahar, M., Mely, Y., Rassam, P., Zimmer, J., Desoubeaux, G., Dervillez, X. & Seguin-Devaux, C., Oct 2025, In: EBioMedicine. 120, 27 p., 105926.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Fighting Antibiotic Resistance: Insights Into Human Barriers and New Opportunities: Antibiotic Resistance Constantly Rises With the Development of Human Activities. We discuss Barriers and Opportunities to Get It Under Control
Pitiot, A., Rolin, C., Seguin-Devaux, C. & Zimmer, J., Jun 2025, In: BioEssays. 47, 6, e70001.Research output: Contribution to journal › Review article › peer-review
Open Access3 Citations (Scopus) -
Synergy between Lactobacillus murinus and anti-PcrV antibody delivered in the airways to boost protection against Pseudomonas aeruginosa
Sécher, T., Cortes, M., Boisseau, C., Barba Goudiaby, M. T., Pitiot, A., Parent, C., Thomas, M. & Heuzé-Vourc'h, N., 12 Dec 2024, In: Molecular Therapy - Methods and Clinical Development. 32, 4, 101330.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
Mucosal administration of anti-bacterial antibodies provide long-term cross-protection against Pseudomonas aeruginosa respiratory infection
Pitiot, A., Ferreira, M., Parent, C., Boisseau, C., Cortes, M., Bouvart, L., Paget, C., Heuzé-Vourc'h, N. & Sécher, T., Jun 2023, In: Mucosal Immunology. 16, 3, p. 312-325 14 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access6 Citations (Scopus)